Quantify

Eli Lilly and Company vs Pfizer, Inc. — Stock Comparison

Eli Lilly and Company (LLY) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

LLY
Eli Lilly and Company
$948.45
▼ 2.72%
vs
PFE
Pfizer, Inc.
$25.68
▼ 1.42%
Q·Score Winner
Eli Lilly and Company
LLY8.3/10vs 6.2/10

Eli Lilly and Company clearly outscores Pfizer, Inc. on Q·Score (8.3 vs 6.2 out of 10), led by Growth (9.7 vs 5.1) and Quality (9 vs 6.4). Analyst consensus targets imply greater upside for LLY (+27.3%) than for PFE (+13.4%).

Q·Score Breakdown

8.3
Bullish
Overall
6.2
Neutral
9
Quality
6.4
7
Health
7
9.7
Growth
5.1
7.8
Valuation
7
7.8
Sentiment
5.2
LLY

Earnings growing 170% year-over-year on 56% revenue growth.

PFE

Consistently beats earnings estimates (4/4 quarters).

⚠ earnings contracting 10% year-over-year.

Analyst Consensus

Bullish
+27.3%
Target $1207.34
29 analysts
Neutral
+13.4%
Target $29.11
27 analysts

Fundamentals

LLY
PFE
33.7×
Trailing P/E
19.6×
21.4×
Forward P/E
9.0×
34.99%
Profit Margin
11.83%
82.83%
Gross Margin
74.80%
107.46%
ROE
8.31%
55.50%
Revenue Growth
5.40%
169.90%
Earnings Growth
-10.10%
0.48
Beta
0.30
0.73%
Dividend Yield
6.70%
$845.8B
Market Cap
$146.4B
52-Week Range
LLY
$62464% of range$1,134
PFE
$2255% of range$29

Frequently Asked Questions

LLY vs PFE: which stock scores better overall?

Based on Q·Score, Eli Lilly and Company (LLY) scores 8.3/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: LLY or PFE?

Eli Lilly and Company (LLY) scores higher on Growth (9.7/10 vs 5.1/10). Eli Lilly and Company reports revenue growth (55.5% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is LLY or PFE more attractively valued?

Eli Lilly and Company (LLY) scores higher on Valuation (7.8/10 vs 7/10). LLY trades at 21.4× P/E versus PFE at 9.0×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about LLY vs PFE?

There are 29 analysts covering LLY with a consensus price target of $1207.34, and 27 analysts covering PFE with a consensus target of $29.11. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: LLY or PFE?

Eli Lilly and Company (LLY) scores higher on Quality (9/10 vs 6.4/10). Net profit margin: LLY at 35.0%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: LLY or PFE?

Eli Lilly and Company (LLY) scores higher on Financial Health (7/10 vs 7/10). Market beta: LLY at 0.48, PFE at 0.30. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of LLY and PFE?

Eli Lilly and Company (LLY) has a market capitalisation of $845.8B, while Pfizer, Inc. (PFE) has a market cap of $146.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do LLY or PFE pay dividends?

LLY pays a dividend yield of 0.73%, while PFE pays a dividend yield of 6.70%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

JNJ vs PFELLY vs NVOMRNA vs PFEABBV vs LLY

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026